Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Faricimab in diabetic macular edema (Rhone-X)
NCT04432831Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2020
- Primary completion
- Oct 2023
- Countries
- 30
01
Overview
A Phase 3 trial of faricimab in diabetic macular edema (DME), sponsored by Roche. Started Aug 2020; status: completed.
02
Drugs
faricimab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04432831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04432831.